Organised by the French Society of Anaesthesia and Intensive Care (SFAR), this annual conference brings together several thousand healthcare professionals to discuss key issues in anaesthesia, intensive care and perioperative medicine. Among these issues is the early detection of complications, particularly infections.

In resuscitation and intensive care, core body temperature is a key physiological indicator. Even a slight variation can signal an emerging infection, sepsis or a post-operative complication. However, monitoring often remains intermittent, even though the clinical situation can change rapidly.

Thermodiag provides an innovative response to this problem. Through continuous, non-invasive and automated monitoring, the device enables:

• close monitoring of temperature changes,
• faster detection of anomalies,
• assistance in prioritising clinical actions,
• reduced handling for the most fragile patients.

F2D Medical’s participation in the SFAR 2025 congress, alongside Luquet & Duranton, is part of a dynamic dialogue with anaesthetists, intensive care specialists, healthcare teams and biomedical engineers, with the aim of exploring concrete use cases for Thermodiag in critical care and supporting the evolution of practices towards more continuous and proactive monitoring.